IMI Introduces VENTURA CPAP, an Alternative Ventilator Solution for COVID-19 Patients
May 19, 2019, Laguna, Philippines. In support of the Philippine government’s call for the local sourcing and manufacturing of low-cost ventilators and other breathing aid solutions in caring for COVID-19 patients all over the country, Integrated Micro-electronics, Inc. (IMI), along with its UK subsidiary Surface Technology International Limited (STI, Ltd) is organizing a series of virtual consultative and information-sharing sessions with medical experts, health practitioners, and concerned government agencies to explore non-invasive alternative ventilatory strategies using the device solution.CPAP is a form of ventilator that applies mild air pressure continuously and effectively supports patients with breathing difficulties. The proposed solution is a non-profit initiative based on an existing off-patent CPAP system that has been further modified to optimize oxygen consumption.
The Ventura CPAP system is approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) for use in the UK. Its design is licensed from the University College London Hospital (UCLH) and Mercedes-AMG High Performance Powertrains under special conditions particularly for use in COVID-19 cases. The proponents in the UK have granted a license to IMI in the manufacturing of the product in the Philippines.
UCLH reported that the use of the Ventura CPAP system has resulted in 60-70% success of sustaining COVID-19 patients needing intubation. The patients eventually went on to full recovery. IMI is working with the Institute of Biomedical Engineering and Health Technologies (IBEHT) of DLSU University in localizing the manufacturing of the system.
In today’s webinar, one of the resource speakers is Nick Davey, IMI’s chief technology officer. Davey set up the Research and Development team in the IMI’s UK subsidiary Surface Technology International Limited (STI Ltd.) in 2011 and is a key member of the UK Ventilator Challenge Consortium, working closely with the UK cabinet officials.
IMI, a global technology and manufacturing solutions expert with its headquarters based in Philippines, is the first to organize this series of multi-industry consultative sessions here in the country. The company along with its UK-based subsidiary STI, Ltd. and local affiliate AC Health, continue to explore various possible ventilator alternative solutions.